Erkki Elonen

Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo–purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group

Christian H. Geisler, Arne Kolstad, Anna Laurell et al. · Blood · 2008 · 619 citations · Full text

Prognostic Subgroups in B-Cell Chronic Lymphocytic Leukemia Defined by Specific Chromosomal Abnormalities

Gunnar Juliusson, David Oscier, M Fitchett et al. · New England Journal of Medicine · 1990 · 607 citations

Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome–positive leukemia

Kimmo Porkka, Perttu Koskenvesa, Tuija Lundán et al. · Blood · 2008 · 437 citations · Full text

Nordic <scp>MCL</scp>2 trial update: six‐year follow‐up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by <scp>BEAM</scp> or <scp>BEAC</scp> + autologous stem‐cell support: still very long survival but late relapses do occur

Christian H. Geisler, Arne Kolstad, Anna Laurell et al. · British Journal of Haematology · 2012 · 265 citations

Cell Therapy, Immunology, Pathology +22

Effect of activated charcoal on absorption and elimination of phenobarbitone, carbamazepine and phenylbutazone in man

Pertti J. Neuvonen, Erkki Elonen · European Journal of Clinical Pharmacology · 1980 · 208 citations

Pharmacological Study, Medicine, Physiology +6